4.9
Pulmonalödem ist die Ansammlung von Flüssigkeit in den interstitiellen und alveolaren Räumen der Lunge, was den Gasaustausch und die Sauerstoffzufuhr…
Ein kardiogenes Lungenödem beginnt typischerweise mit einer Funktionsstörung des linken Ventrikels, wie sie bei Herzinsuffizienz zu beobachten ist.
Dies erhöht den hydrostatischen Druck in den pulmonalen Kapillaren, wodurch sich die Flüssigkeit von der Kapillare in den interstitiellen Raum bewegt und die Alveolen überflutet.
Andererseits ist bei nichtkardiogenem Ödem der Hauptmechanismus eine erhöhte Kapillardurchlässigkeit, die oft durch das Auftreten eines akuten Atemnotsyndroms oder eine toxische Einatmung ausgelöst wird.
Proteinreiche Flüssigkeit tritt in die Alveolen ab und zieht osmotisch zusätzliches Wasser an.
In beiden Fällen stört Alveolarflüssigkeit das Tensid, erhöht die Oberflächenspannung und verringert die Lungennachlässigkeit, was das Atmen erschwert. Der Gasaustausch nimmt aufgrund der erhöhten Diffusionsdistanz und der Diskrepanz zwischen Belüftung und Perfusion ab.
Bleibt das Lungenödem unbehandelt, kann es zu Atemversagen übergehen, das durch schwere Atemnot oder Atemnot gekennzeichnet ist; Hypoxämie oder niedriger Sauerstoffmangel im Blut; und Hyperkapnie, also erhöhte Kohlendioxidwerte.
View the full transcript and gain access to JoVE Core videos
Q1: What causes cardiogenic pulmonary edema?
Cardiogenic pulmonary edema results from left ventricular dysfunction, commonly seen in heart failure, myocardial infarction, or valvular disease. This dysfunction raises hydrostatic pressure in pulmonary capillaries, disrupting the balance between hydrostatic and oncotic forces. Fluid moves from capillaries into interstitial and alveolar spaces, impairing gas exchange and causing hypoxemia and dyspnea.
Q2: How does noncardiogenic pulmonary edema develop differently from cardiogenic edema?
Noncardiogenic edema occurs with normal hydrostatic pressure but increased capillary permeability due to injury or inflammation of the alveolar-capillary membrane. Conditions like acute respiratory distress syndrome or toxic inhalation damage endothelial barriers, allowing protein-rich fluid to leak into alveoli. This high-protein fluid draws in additional water osmotically, worsening edema without cardiac dysfunction.
Q3: How does pulmonary edema affect lung compliance and breathing?
Fluid accumulation in alveoli disrupts surfactant, increases surface tension, and reduces lung compliance, making alveolar expansion difficult. Increased diffusion distance and ventilation-perfusion mismatch further impair gas exchange. These changes force the respiratory muscles to work harder, increasing breathing effort and contributing to dyspnea and reduced oxygenation.
Q4: What are the severe complications of untreated pulmonary edema?
Untreated pulmonary edema can progress to acute respiratory failure, characterized by severe dyspnea, hypoxemia (low blood oxygen), and hypercapnia (elevated carbon dioxide). Fluid-filled alveoli cannot participate in gas exchange, leading to refractory hypoxemia. Prompt identification of the underlying cause is critical, as cardiogenic and noncardiogenic edema require distinct treatment strategies to restore adequate gas exchange.
Q5: Why does protein-rich fluid worsen noncardiogenic pulmonary edema?
In noncardiogenic edema, damaged alveolar-capillary membranes allow protein-rich fluid to leak into alveoli. The high protein concentration creates an osmotic gradient that draws additional water into the alveolar space, amplifying fluid accumulation. This mechanism differs from cardiogenic edema, where hydrostatic pressure drives fluid movement without significant protein leakage.
Q6: How does pulmonary edema impair gas exchange?
Fluid-filled alveoli cannot participate in gas exchange, increasing the diffusion distance between blood and air. Ventilation-perfusion mismatch occurs when fluid blocks ventilation to perfused areas. Together, these changes reduce oxygen uptake and carbon dioxide elimination, causing hypoxemia and hypercapnia that characterize respiratory failure if severe.
Q7: Why is distinguishing between cardiogenic and noncardiogenic edema important for treatment?
Cardiogenic and noncardiogenic pulmonary edema require distinct treatment strategies because they result from different pathophysiologic mechanisms. Cardiogenic edema stems from left ventricular dysfunction and elevated hydrostatic pressure, while noncardiogenic edema involves increased capillary permeability. Patients with respiratory complications may also benefit from understanding chronic obstructive pulmonary disease clinical manifestations to recognize overlapping symptoms.